Specifically, interleukin‐6 (IL‐6), a prominent pro‐inflammatory cytokine, is recognized as a primary instigator of plaque destabilization, atheroprogression, and the generation of high‐sensitivity C‐reactive protein (hs‐CRP), thereby fostering the onset and progression of clinical atherosclerosis. This evidence concerns the gene IL6 and atherosclerosis.